Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 134

1.

Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity.

Blüher M, Engeli S, Klöting N, Berndt J, Fasshauer M, Bátkai S, Pacher P, Schön MR, Jordan J, Stumvoll M.

Diabetes. 2006 Nov;55(11):3053-60.

2.

Activation of the peripheral endocannabinoid system in human obesity.

Engeli S, Böhnke J, Feldpausch M, Gorzelniak K, Janke J, Bátkai S, Pacher P, Harvey-White J, Luft FC, Sharma AM, Jordan J.

Diabetes. 2005 Oct;54(10):2838-43.

3.

Adipose tissue endocannabinoid system gene expression: depot differences and effects of diet and exercise.

You T, Disanzo BL, Wang X, Yang R, Gong D.

Lipids Health Dis. 2011 Oct 28;10:194. doi: 10.1186/1476-511X-10-194.

4.

Influence of dietary fat intake on the endocannabinoid system in lean and obese subjects.

Engeli S, Lehmann AC, Kaminski J, Haas V, Janke J, Zoerner AA, Luft FC, Tsikas D, Jordan J.

Obesity (Silver Spring). 2014 May;22(5):E70-6. doi: 10.1002/oby.20728. Epub 2014 Mar 11.

5.

Investigations of the human endocannabinoid system in two subcutaneous adipose tissue depots in lean subjects and in obese subjects before and after weight loss.

Bennetzen MF, Wellner N, Ahmed SS, Ahmed SM, Diep TA, Hansen HS, Richelsen B, Pedersen SB.

Int J Obes (Lond). 2011 Nov;35(11):1377-84. doi: 10.1038/ijo.2011.8. Epub 2011 Feb 15.

PMID:
21326208
6.

Insulin differentially modulates the peripheral endocannabinoid system in human subcutaneous abdominal adipose tissue from lean and obese individuals.

Murdolo G, Kempf K, Hammarstedt A, Herder C, Smith U, Jansson PA.

J Endocrinol Invest. 2007 Sep;30(8):RC17-21.

PMID:
17923791
7.

Plasma visfatin concentrations and fat depot-specific mRNA expression in humans.

Berndt J, Klöting N, Kralisch S, Kovacs P, Fasshauer M, Schön MR, Stumvoll M, Blüher M.

Diabetes. 2005 Oct;54(10):2911-6.

8.

Endocannabinoid dysregulation in the pancreas and adipose tissue of mice fed with a high-fat diet.

Starowicz KM, Cristino L, Matias I, Capasso R, Racioppi A, Izzo AA, Di Marzo V.

Obesity (Silver Spring). 2008 Mar;16(3):553-65. doi: 10.1038/oby.2007.106. Epub 2008 Jan 17.

9.

Regulation, function, and dysregulation of endocannabinoids in models of adipose and beta-pancreatic cells and in obesity and hyperglycemia.

Matias I, Gonthier MP, Orlando P, Martiadis V, De Petrocellis L, Cervino C, Petrosino S, Hoareau L, Festy F, Pasquali R, Roche R, Maj M, Pagotto U, Monteleone P, Di Marzo V.

J Clin Endocrinol Metab. 2006 Aug;91(8):3171-80. Epub 2006 May 9.

PMID:
16684820
10.

The fatty acid transporter FAT/CD36 is upregulated in subcutaneous and visceral adipose tissues in human obesity and type 2 diabetes.

Bonen A, Tandon NN, Glatz JF, Luiken JJ, Heigenhauser GJ.

Int J Obes (Lond). 2006 Jun;30(6):877-83.

PMID:
16418758
11.

Subcutaneous abdominal fat and thigh muscle composition predict insulin sensitivity independently of visceral fat.

Goodpaster BH, Thaete FL, Simoneau JA, Kelley DE.

Diabetes. 1997 Oct;46(10):1579-85.

PMID:
9313753
12.

Visceral adipose tissue is not increased in Pima Indians compared with equally obese Caucasians and is not related to insulin action or secretion.

Gautier JF, Milner MR, Elam E, Chen K, Ravussin E, Pratley RE.

Diabetologia. 1999 Jan;42(1):28-34.

PMID:
10027574
13.

Circulating endocannabinoid levels, abdominal adiposity and related cardiometabolic risk factors in obese men.

Côté M, Matias I, Lemieux I, Petrosino S, Alméras N, Després JP, Di Marzo V.

Int J Obes (Lond). 2007 Apr;31(4):692-9. Epub 2007 Jan 16.

PMID:
17224929
14.

The activity of the endocannabinoid metabolising enzyme fatty acid amide hydrolase in subcutaneous adipocytes correlates with BMI in metabolically healthy humans.

Cable JC, Tan GD, Alexander SP, O'Sullivan SE.

Lipids Health Dis. 2011 Aug 4;10:129. doi: 10.1186/1476-511X-10-129.

15.

Peripheral endocannabinoid system activity in patients treated with sibutramine.

Engeli S, Heusser K, Janke J, Gorzelniak K, Bátkai S, Pacher P, Harvey-White J, Luft FC, Jordan J.

Obesity (Silver Spring). 2008 May;16(5):1135-7. doi: 10.1038/oby.2008.47. Epub 2008 Mar 6.

16.

Postprandial triglyceride response in visceral obesity in men.

Couillard C, Bergeron N, Prud'homme D, Bergeron J, Tremblay A, Bouchard C, Mauriège P, Després JP.

Diabetes. 1998 Jun;47(6):953-60.

PMID:
9604874
17.

Regional abdominal fat distribution in lean and obese Thai type 2 diabetic women: relationships with insulin sensitivity and cardiovascular risk factors.

Rattarasarn C, Leelawattana R, Soonthornpun S, Setasuban W, Thamprasit A, Lim A, Chayanunnukul W, Thamkumpee N, Daendumrongsub T.

Metabolism. 2003 Nov;52(11):1444-7.

PMID:
14624404
18.

Body fat distribution in pre- and post-menopausal women: metabolic and anthropometric variables and their inter-relationships.

Zamboni M, Armellini F, Milani MP, De Marchi M, Todesco T, Robbi R, Bergamo-Andreis IA, Bosello O.

Int J Obes Relat Metab Disord. 1992 Jul;16(7):495-504.

PMID:
1323546
19.

Altered pattern of cannabinoid type 1 receptor expression in adipose tissue of dysmetabolic and overweight patients.

Sarzani R, Bordicchia M, Marcucci P, Bedetta S, Santini S, Giovagnoli A, Scappini L, Minardi D, Muzzonigro G, Dessì-Fulgheri P, Rappelli A.

Metabolism. 2009 Mar;58(3):361-7. doi: 10.1016/j.metabol.2008.10.009.

PMID:
19217452
20.

Contribution of abdominal adiposity to age-related differences in insulin sensitivity and plasma lipids in healthy nonobese women.

DeNino WF, Tchernof A, Dionne IJ, Toth MJ, Ades PA, Sites CK, Poehlman ET.

Diabetes Care. 2001 May;24(5):925-32.

PMID:
11347756
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk